Biotech companies operate in a high-stakes environment where capital efficiency, IP protection, and regulatory readiness are key. From early-stage R&D firms to pre-revenue startups navigating clinical trials, financial infrastructure must support funding rounds, grant compliance, and long-term scalability.

Industry-specific support includes cost tracking for R&D expenditures, preparation for SBIR/STTR grant audits, revenue modeling for licensing agreements, and planning for IPO or acquisition. Precision in financial reporting and investor communications is essential in the biotech lifecycle.